Abacavir/Lamivudin Aurobindo

Abacavir/Lamivudine Aurobindo is a combination medication used in the treatment of HIV infection. This oral medication is manufactured by Puren Pharma GmbH & Co. KG and is available in the EU market.

Abacavir/Lamivudine Aurobindo is primarily used in the management of HIV infection. This combination therapy works by reducing the amount of HIV in the body, helping to control the progression of the disease. It is often prescribed as part of a broader antiretroviral treatment regimen. Patients should consult their healthcare provider to understand what Abacavir/Lamivudine is used for in their specific case.

Common effects of Abacavir/Lamivudine Aurobindo may include fatigue, headache, and nausea. Some individuals might experience dizziness or insomnia. These effects can vary widely among users, and not everyone will experience them. It is important to monitor any unusual symptoms and discuss them with a healthcare professional.

Abacavir/Lamivudine Aurobindo should be handled with care, especially for individuals with a history of liver or kidney problems. It is crucial to follow the prescribed dosage and administration instructions. Patients should avoid alcohol while taking this medication, as it may increase the risk of side effects. Always store the medication in a cool, dry place away from direct sunlight.

Abacavir/Lamivudine Aurobindo may interact with other medications, including certain antiviral drugs and immune modulators. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect liver function should be avoided while on this medication.